Mind-Body Medicine for Lymphoma
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if meditation, a form of mind-body medicine, can improve the quality of life for young people with lymphoma, a type of cancer. It will explore whether meditation reduces feelings of distress, depression, and anxiety. Participants will join either a meditation group or an educational group, attending weekly sessions for five weeks. Suitable candidates have been diagnosed with lymphoma in the last six months and have internet access. As an unphased trial, this study offers a unique opportunity to explore meditation's potential benefits in enhancing well-being during cancer treatment.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It focuses on a mind-body intervention, so it's best to ask the trial coordinators for more details.
What prior data suggests that this mind-body intervention is safe for adolescents and young adults with lymphoma?
Research has shown that mind-body practices, such as meditation, are very safe. Studies indicate that patients, including those with cancer, respond well to these methods. Most people do not experience serious side effects. These practices primarily aim to improve mental health by reducing anxiety and stress, making them a gentle and safe option for many. Thus, participating in a trial that includes meditation should be a safe choice, particularly if the goal is to enhance quality of life.12345
Why are researchers excited about this trial?
Researchers are excited about mind-body medicine for lymphoma because it offers a holistic approach that could complement existing treatments like chemotherapy and radiation. Unlike conventional treatments that target the cancer cells directly, mind-body techniques focus on reducing stress and improving quality of life through meditation and educational sessions. This method aims to harness the power of the mind to support the body's natural healing processes, potentially enhancing overall well-being and resilience during cancer treatment.
What evidence suggests that this mind-body intervention is effective for improving quality of life in adolescents and young adults with lymphoma?
Research shows that activities like meditation can improve the quality of life for cancer patients. Studies have found that these practices reduce stress and boost mood in cancer survivors. For example, a large study found that mindfulness and Tai Chi improved mood in people experiencing cancer-related distress. Another study showed that mindfulness programs significantly enhanced quality of life compared to those who did not participate. In this trial, participants in Group I will attend meditation sessions, which may help adolescents and young adults with lymphoma by reducing distress, depression, and anxiety. Meanwhile, participants in Group II will attend educational sessions, serving as an active comparator to evaluate meditation's effects.16789
Who Is on the Research Team?
Kathrin Milbury, MA,PHD
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
This trial is for young adults aged 18-39 recently diagnosed with any stage of Lymphoma. They should be relatively active (ECOG status 2 or below), have internet access, and be fluent in English. It's not suitable for those with major psychiatric issues or who are already in regular psychotherapy or cancer support groups.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants attend meditation or educational group sessions once weekly for up to 5 weeks
Follow-up
Participants are monitored for psychological distress and cancer symptoms after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Mind-Body Medicine
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator